<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-10-03" modified="2020-10-07" version="166">
<accession>O60502</accession>
<accession>B7WPB9</accession>
<accession>D3DR79</accession>
<accession>E9PGF9</accession>
<accession>O75166</accession>
<accession>Q86WV0</accession>
<accession>Q8IV98</accession>
<accession>Q9BVA5</accession>
<accession>Q9HAR0</accession>
<name>OGA_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="29 30 33">Protein O-GlcNAcase</fullName>
<shortName evidence="31">OGA</shortName>
<ecNumber evidence="18 20 23 25 26 35">3.2.1.169</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="29">Beta-N-acetylglucosaminidase</fullName>
</alternativeName>
<alternativeName>
<fullName>Beta-N-acetylhexosaminidase</fullName>
</alternativeName>
<alternativeName>
<fullName>Beta-hexosaminidase</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="32">Meningioma-expressed antigen 5</fullName>
</alternativeName>
<alternativeName>
<fullName>N-acetyl-beta-D-glucosaminidase</fullName>
</alternativeName>
<alternativeName>
<fullName>N-acetyl-beta-glucosaminidase</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear cytoplasmic O-GlcNAcase and acetyltransferase</fullName>
<shortName>NCOAT</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="37">OGA</name>
<name type="synonym">HEXC</name>
<name type="synonym">KIAA0679</name>
<name type="synonym">MEA5</name>
<name type="synonym">MGEA5</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Hum. Mol. Genet." volume="7" first="1859" last="1872">
<title>Novel immunogenic antigen homologous to hyaluronidase in meningioma.</title>
<authorList>
<person name="Heckel D."/>
<person name="Comtesse N."/>
<person name="Brass N."/>
<person name="Blin N."/>
<person name="Zang K.D."/>
<person name="Meese E."/>
</authorList>
<dbReference type="PubMed" id="9811929"/>
<dbReference type="DOI" id="10.1093/hmg/7.12.1859"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3)</scope>
<source>
<tissue>Meningioma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="283" first="634" last="640">
<title>Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase.</title>
<authorList>
<person name="Comtesse N."/>
<person name="Maldener E."/>
<person name="Meese E."/>
</authorList>
<dbReference type="PubMed" id="11341771"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.4815"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 3)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="9838" last="9845">
<title>Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.</title>
<authorList>
<person name="Gao Y."/>
<person name="Wells L."/>
<person name="Comer F.I."/>
<person name="Parker G.J."/>
<person name="Hart G.W."/>
</authorList>
<dbReference type="PubMed" id="11148210"/>
<dbReference type="DOI" id="10.1074/jbc.m010420200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1998" name="DNA Res." volume="5" first="169" last="176">
<title>Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.</title>
<authorList>
<person name="Ishikawa K."/>
<person name="Nagase T."/>
<person name="Suyama M."/>
<person name="Miyajima N."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="9734811"/>
<dbReference type="DOI" id="10.1093/dnares/5.3.169"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="DNA Res." volume="9" first="99" last="106">
<title>Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.</title>
<authorList>
<person name="Nakajima D."/>
<person name="Okazaki N."/>
<person name="Yamakawa H."/>
<person name="Kikuno R."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
</authorList>
<dbReference type="PubMed" id="12168954"/>
<dbReference type="DOI" id="10.1093/dnares/9.3.99"/>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT LYS-602</scope>
<source>
<tissue>Cervix</tissue>
<tissue>Eye</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="1755" last="1761">
<title>Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.</title>
<authorList>
<person name="Wells L."/>
<person name="Gao Y."/>
<person name="Mahoney J.A."/>
<person name="Vosseller K."/>
<person name="Chen C."/>
<person name="Rosen A."/>
<person name="Hart G.W."/>
</authorList>
<dbReference type="PubMed" id="11788610"/>
<dbReference type="DOI" id="10.1074/jbc.m109656200"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBUNIT</scope>
<scope>PTM</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Biochemistry" volume="45" first="3835" last="3844">
<title>Identification of Asp174 and Asp175 as the key catalytic residues of human O-GlcNAcase by functional analysis of site-directed mutants.</title>
<authorList>
<person name="Cetinbas N."/>
<person name="Macauley M.S."/>
<person name="Stubbs K.A."/>
<person name="Drapala R."/>
<person name="Vocadlo D.J."/>
</authorList>
<dbReference type="PubMed" id="16533067"/>
<dbReference type="DOI" id="10.1021/bi052370b"/>
</citation>
<scope>ACTIVE SITE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF ASP-174 AND ASP-175</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="23557" last="23566">
<title>Characterization of beta-N-acetylglucosaminidase cleavage by caspase-3 during apoptosis.</title>
<authorList>
<person name="Butkinaree C."/>
<person name="Cheung W.D."/>
<person name="Park S."/>
<person name="Park K."/>
<person name="Barber M."/>
<person name="Hart G.W."/>
</authorList>
<dbReference type="PubMed" id="18586680"/>
<dbReference type="DOI" id="10.1074/jbc.m804116200"/>
</citation>
<scope>PTM</scope>
<scope>SITE</scope>
<scope>MUTAGENESIS OF ASP-413</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="Biochem. J." volume="432" first="1" last="7">
<title>Human OGA binds substrates in a conserved peptide recognition groove.</title>
<authorList>
<person name="Schimpl M."/>
<person name="Schuttelkopf A.W."/>
<person name="Borodkin V.S."/>
<person name="van Aalten D.M."/>
</authorList>
<dbReference type="PubMed" id="20863279"/>
<dbReference type="DOI" id="10.1042/bj20101338"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF TYR-69; ASP-175; VAL-255; TYR-286; ASP-287 AND TRP-679</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Biochemistry (Mosc.)" volume="75" first="938" last="943">
<title>Isoforms of human O-GlcNAcase show distinct catalytic efficiencies.</title>
<authorList>
<person name="Li J."/>
<person name="Huang C.L."/>
<person name="Zhang L.W."/>
<person name="Lin L."/>
<person name="Li Z.H."/>
<person name="Zhang F.W."/>
<person name="Wang P."/>
</authorList>
<dbReference type="PubMed" id="20673219"/>
<dbReference type="DOI" id="10.1134/s0006297910070175"/>
</citation>
<scope>FUNCTION OF ISOFORMS 1 AND 3</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2013" name="Open Biol." volume="3" first="130021" last="130021">
<title>Structure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domain.</title>
<authorList>
<person name="Rao F.V."/>
<person name="Schuttelkopf A.W."/>
<person name="Dorfmueller H.C."/>
<person name="Ferenbach A.T."/>
<person name="Navratilova I."/>
<person name="van Aalten D.M."/>
</authorList>
<dbReference type="PubMed" id="24088714"/>
<dbReference type="DOI" id="10.1098/rsob.130021"/>
</citation>
<scope>LACK OF ACETYLTRANSFERASE ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2017" name="PLoS Pathog." volume="13" first="E1006518" last="E1006518">
<title>Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.</title>
<authorList>
<person name="Groussaud D."/>
<person name="Khair M."/>
<person name="Tollenaere A.I."/>
<person name="Waast L."/>
<person name="Kuo M.S."/>
<person name="Mangeney M."/>
<person name="Martella C."/>
<person name="Fardini Y."/>
<person name="Coste S."/>
<person name="Souidi M."/>
<person name="Benit L."/>
<person name="Pique C."/>
<person name="Issad T."/>
</authorList>
<dbReference type="PubMed" id="28742148"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1006518"/>
</citation>
<scope>INTERACTION WITH HUMAN T-CELL LEUKEMIA VIRUS 1/HTLV-1 PROTEIN TAX</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Chem. Biol." volume="19" first="173" last="178">
<title>Synergy of peptide and sugar in O-GlcNAcase substrate recognition.</title>
<authorList>
<person name="Schimpl M."/>
<person name="Borodkin V.S."/>
<person name="Gray L.J."/>
<person name="van Aalten D.M."/>
</authorList>
<dbReference type="PubMed" id="22365600"/>
<dbReference type="DOI" id="10.1016/j.chembiol.2012.01.011"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 402-408</scope>
<scope>MUTAGENESIS OF TYR-69</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<comment type="function">
<molecule>Isoform 1</molecule>
<text evidence="18 20 24 26 27">Cleaves GlcNAc but not GalNAc from O-glycosylated proteins. Can use p-nitrophenyl-beta-GlcNAc and 4-methylumbelliferone-GlcNAc as substrates but not p-nitrophenyl-beta-GalNAc or p-nitrophenyl-alpha-GlcNAc (in vitro) (PubMed:11148210). Does not bind acetyl-CoA and does not have histone acetyltransferase activity (PubMed:24088714).</text>
</comment>
<comment type="function">
<molecule>Isoform 3</molecule>
<text evidence="24">Cleaves GlcNAc but not GalNAc from O-glycosylated proteins. Can use p-nitrophenyl-beta-GlcNAc as substrate but not p-nitrophenyl-beta-GalNAc or p-nitrophenyl-alpha-GlcNAc (in vitro), but has about six times lower specific activity than isoform 1.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="18 20 23 25 26 35">
<text>3-O-(N-acetyl-beta-D-glucosaminyl)-L-seryl-[protein] + H2O = L-seryl-[protein] + N-acetyl-D-glucosamine</text>
<dbReference type="Rhea" id="RHEA:48876"/>
<dbReference type="Rhea" id="RHEA-COMP:9863"/>
<dbReference type="Rhea" id="RHEA-COMP:12251"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:29999"/>
<dbReference type="ChEBI" id="CHEBI:90838"/>
<dbReference type="ChEBI" id="CHEBI:506227"/>
<dbReference type="EC" id="3.2.1.169"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="18 20 23 25 26 35">
<text>3-O-(N-acetyl-beta-D-glucosaminyl)-L-threonyl-[protein] + H2O = L-threonyl-[protein] + N-acetyl-D-glucosamine</text>
<dbReference type="Rhea" id="RHEA:48892"/>
<dbReference type="Rhea" id="RHEA-COMP:11060"/>
<dbReference type="Rhea" id="RHEA-COMP:12252"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:30013"/>
<dbReference type="ChEBI" id="CHEBI:90840"/>
<dbReference type="ChEBI" id="CHEBI:506227"/>
<dbReference type="EC" id="3.2.1.169"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="18">Inhibited by N-acetylglucosamine and not N-acetylgalactosamine.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="20">1.1 mM for pNP-GlcNAc</KM>
<Vmax evidence="20">652 umol/min/mg enzyme with pNP-GLcNAc as substrate</Vmax>
</kinetics>
<phDependence>
<text evidence="18">Optimum pH is 5.7-7.</text>
</phDependence>
</comment>
<comment type="subunit">
<text evidence="17 20">Monomer (PubMed:11788610). Interacts with CLOCK (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="28">(Microbial infection) Interacts with human T-cell leukemia virus 1/HTLV-1 protein Tax; this interaction increases Tax interacting partner CREB1 O-GlcNAcylation.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location evidence="19">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="18 19 20">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O60502-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O60502-2</id>
<name>2</name>
<sequence type="described" ref="VSP_020866 VSP_020869"/>
</isoform>
<isoform>
<id>O60502-3</id>
<name>3</name>
<name>MGEA5s</name>
<sequence type="described" ref="VSP_020867 VSP_020868"/>
</isoform>
<isoform>
<id>O60502-4</id>
<name>4</name>
<sequence type="described" ref="VSP_020866"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="18 19">Ubiquitous. Shows highest expression in the brain, placenta and pancreas.</text>
</comment>
<comment type="PTM">
<text evidence="20 23">Proteolytically cleaved by caspase-3 during apoptosis. The fragments interact with each other; cleavage does not decrease enzyme activity.</text>
</comment>
<comment type="similarity">
<text evidence="33">Belongs to the glycosyl hydrolase 84 family.</text>
</comment>
<comment type="caution">
<text evidence="27 36">The mouse and rat orthologs were initially identified as bi-functional proteins containing an N-terminal domain with O-GlcNAcase activity and a C-terminal domain with histone acetyltransferase activity. The histone acetyltransferase activity was detected only when the protein was expressed in mammalian cells, but not when expressed in bacterial cells, suggesting that the histone acetyltransferase activity might be due to the presence of a contaminant. Comparison of the human protein with a bacterial putative acetyltransferase (AC Q2CEE2) shows that the residues important for acetyl-CoA binding are not conserved, and that the residues proposed to be important for histone acetyltransferase activity are not in a position where they could participate in catalysis. Characterization of the human protein shows that it does not bind acetyl-CoA and therefore cannot have acetyltransferase activity.</text>
</comment>
<comment type="sequence caution" evidence="33">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH47877" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="sequence caution" evidence="33">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA31654" version="2"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EC" id="3.2.1.169" evidence="18 20 23 25 26 35"/>
<dbReference type="EMBL" id="AF036144">
<property type="protein sequence ID" value="AAD05385.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF307332">
<property type="protein sequence ID" value="AAG21428.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB014579">
<property type="protein sequence ID" value="BAA31654.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC010789">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW49744.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW49741.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471066">
<property type="protein sequence ID" value="EAW49742.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001343">
<property type="protein sequence ID" value="AAH01343.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC039583">
<property type="protein sequence ID" value="AAH39583.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC047877">
<property type="protein sequence ID" value="AAH47877.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44471.1">
<molecule id="O60502-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7520.1">
<molecule id="O60502-1"/>
</dbReference>
<dbReference type="PIR" id="T00360">
<property type="entry name" value="T00360"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001135906.1">
<molecule id="O60502-4"/>
<property type="nucleotide sequence ID" value="NM_001142434.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_036347.1">
<molecule id="O60502-1"/>
<property type="nucleotide sequence ID" value="NM_012215.3"/>
</dbReference>
<dbReference type="PDB" id="2YDQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="T=402-408"/>
</dbReference>
<dbReference type="PDB" id="5M7R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B=1-916"/>
</dbReference>
<dbReference type="PDB" id="5M7S">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=1-916"/>
</dbReference>
<dbReference type="PDB" id="5M7T">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=1-916"/>
</dbReference>
<dbReference type="PDB" id="5M7U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=1-916"/>
</dbReference>
<dbReference type="PDB" id="5TKE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.48"/>
<property type="chains" value="A/B=60-400, A/B=553-704"/>
</dbReference>
<dbReference type="PDB" id="5UHK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.97"/>
<property type="chains" value="A/C=56-400, B/D=544-705"/>
</dbReference>
<dbReference type="PDB" id="5UHL">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.14"/>
<property type="chains" value="A/C=56-400, B/D=544-705"/>
</dbReference>
<dbReference type="PDB" id="5UHO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.21"/>
<property type="chains" value="A/C=56-400, B/D=544-705"/>
</dbReference>
<dbReference type="PDB" id="5UHP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A/B/C/D=14-400, E/F/G/H=554-705"/>
</dbReference>
<dbReference type="PDB" id="5UN8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.13"/>
<property type="chains" value="A/B/C/D=60-400, A/B/C/D=553-704"/>
</dbReference>
<dbReference type="PDB" id="5UN9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=60-400, A/B=553-704"/>
</dbReference>
<dbReference type="PDB" id="5VVO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=60-400, A/B=553-704"/>
</dbReference>
<dbReference type="PDB" id="5VVT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/C=60-400, A/C=553-704"/>
</dbReference>
<dbReference type="PDB" id="5VVU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/C=60-400, A/C=553-704"/>
</dbReference>
<dbReference type="PDB" id="5VVV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/C=60-400, A/C=553-704"/>
</dbReference>
<dbReference type="PDB" id="5VVX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/C=60-400, A/C=553-704"/>
</dbReference>
<dbReference type="PDB" id="6HKI">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=1-916"/>
</dbReference>
<dbReference type="PDB" id="6PM9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.86"/>
<property type="chains" value="A/B/C/D=14-400, E/F/G/H=553-705"/>
</dbReference>
<dbReference type="PDBsum" id="2YDQ"/>
<dbReference type="PDBsum" id="5M7R"/>
<dbReference type="PDBsum" id="5M7S"/>
<dbReference type="PDBsum" id="5M7T"/>
<dbReference type="PDBsum" id="5M7U"/>
<dbReference type="PDBsum" id="5TKE"/>
<dbReference type="PDBsum" id="5UHK"/>
<dbReference type="PDBsum" id="5UHL"/>
<dbReference type="PDBsum" id="5UHO"/>
<dbReference type="PDBsum" id="5UHP"/>
<dbReference type="PDBsum" id="5UN8"/>
<dbReference type="PDBsum" id="5UN9"/>
<dbReference type="PDBsum" id="5VVO"/>
<dbReference type="PDBsum" id="5VVT"/>
<dbReference type="PDBsum" id="5VVU"/>
<dbReference type="PDBsum" id="5VVV"/>
<dbReference type="PDBsum" id="5VVX"/>
<dbReference type="PDBsum" id="6HKI"/>
<dbReference type="PDBsum" id="6PM9"/>
<dbReference type="SMR" id="O60502"/>
<dbReference type="BioGRID" id="115948">
<property type="interactions" value="42"/>
</dbReference>
<dbReference type="IntAct" id="O60502">
<property type="interactions" value="33"/>
</dbReference>
<dbReference type="MINT" id="O60502"/>
<dbReference type="STRING" id="9606.ENSP00000354850"/>
<dbReference type="BindingDB" id="O60502"/>
<dbReference type="ChEMBL" id="CHEMBL5921"/>
<dbReference type="DrugBank" id="DB00428">
<property type="generic name" value="Streptozocin"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="3101"/>
<dbReference type="CAZy" id="GH84">
<property type="family name" value="Glycoside Hydrolase Family 84"/>
</dbReference>
<dbReference type="GlyGen" id="O60502">
<property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="O60502"/>
<dbReference type="MetOSite" id="O60502"/>
<dbReference type="PhosphoSitePlus" id="O60502"/>
<dbReference type="SwissPalm" id="O60502"/>
<dbReference type="BioMuta" id="MGEA5"/>
<dbReference type="CPTAC" id="CPTAC-1223"/>
<dbReference type="EPD" id="O60502"/>
<dbReference type="jPOST" id="O60502"/>
<dbReference type="MassIVE" id="O60502"/>
<dbReference type="MaxQB" id="O60502"/>
<dbReference type="PaxDb" id="O60502"/>
<dbReference type="PeptideAtlas" id="O60502"/>
<dbReference type="PRIDE" id="O60502"/>
<dbReference type="ProteomicsDB" id="20314"/>
<dbReference type="ProteomicsDB" id="49438">
<molecule id="O60502-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="49439">
<molecule id="O60502-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="49440">
<molecule id="O60502-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="31340">
<property type="antibodies" value="166 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="10724"/>
<dbReference type="Ensembl" id="ENST00000357797">
<molecule id="O60502-2"/>
<property type="protein sequence ID" value="ENSP00000350445"/>
<property type="gene ID" value="ENSG00000198408"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000361464">
<molecule id="O60502-1"/>
<property type="protein sequence ID" value="ENSP00000354850"/>
<property type="gene ID" value="ENSG00000198408"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000370094">
<molecule id="O60502-3"/>
<property type="protein sequence ID" value="ENSP00000359112"/>
<property type="gene ID" value="ENSG00000198408"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000439817">
<molecule id="O60502-4"/>
<property type="protein sequence ID" value="ENSP00000409973"/>
<property type="gene ID" value="ENSG00000198408"/>
</dbReference>
<dbReference type="GeneID" id="10724"/>
<dbReference type="KEGG" id="hsa:10724"/>
<dbReference type="UCSC" id="uc001ktv.3">
<molecule id="O60502-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10724"/>
<dbReference type="DisGeNET" id="10724"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000198408.13"/>
<dbReference type="GeneCards" id="OGA"/>
<dbReference type="HGNC" id="HGNC:7056">
<property type="gene designation" value="OGA"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000198408">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="604039">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O60502"/>
<dbReference type="OpenTargets" id="ENSG00000198408"/>
<dbReference type="PharmGKB" id="PA30787"/>
<dbReference type="eggNOG" id="KOG3698">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000007726"/>
<dbReference type="HOGENOM" id="CLU_009837_1_0_1"/>
<dbReference type="InParanoid" id="O60502"/>
<dbReference type="KO" id="K15719"/>
<dbReference type="OMA" id="QFGCEAY"/>
<dbReference type="OrthoDB" id="159999at2759"/>
<dbReference type="PhylomeDB" id="O60502"/>
<dbReference type="TreeFam" id="TF313732"/>
<dbReference type="BioCyc" id="MetaCyc:HS03036-MONOMER"/>
<dbReference type="BRENDA" id="3.2.1.35">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="O60502"/>
<dbReference type="BioGRID-ORCS" id="10724">
<property type="hits" value="93 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MGEA5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="MGEA5"/>
<dbReference type="GenomeRNAi" id="10724"/>
<dbReference type="Pharos" id="O60502">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:O60502"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="RNAct" id="O60502">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000198408">
<property type="expression patterns" value="Expressed in forebrain and 244 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O60502">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O60502">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0102167">
<property type="term" value="F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0102571">
<property type="term" value="F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0102166">
<property type="term" value="F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0016231">
<property type="term" value="F:beta-N-acetylglucosaminidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004415">
<property type="term" value="F:hyalurononglucosaminidase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006516">
<property type="term" value="P:glycoprotein catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0009100">
<property type="term" value="P:glycoprotein metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006044">
<property type="term" value="P:N-acetylglucosamine metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006517">
<property type="term" value="P:protein deglycosylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006493">
<property type="term" value="P:protein O-linked glycosylation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="DisProt" id="DP02479"/>
<dbReference type="IDEAL" id="IID00643"/>
<dbReference type="InterPro" id="IPR016181">
<property type="entry name" value="Acyl_CoA_acyltransferase"/>
</dbReference>
<dbReference type="InterPro" id="IPR011496">
<property type="entry name" value="Beta-N-acetylglucosaminidase"/>
</dbReference>
<dbReference type="InterPro" id="IPR017853">
<property type="entry name" value="Glycoside_hydrolase_SF"/>
</dbReference>
<dbReference type="Pfam" id="PF07555">
<property type="entry name" value="NAGidase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51445">
<property type="entry name" value="SSF51445"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55729">
<property type="entry name" value="SSF55729"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0326">Glycosidase</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="chain" description="Protein O-GlcNAcase" id="PRO_0000252118">
<location>
<begin position="1"/>
<end position="916"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="16">
<location>
<begin position="278"/>
<end position="280"/>
</location>
</feature>
<feature type="active site" description="Proton donor" evidence="34">
<location>
<position position="175"/>
</location>
</feature>
<feature type="binding site" description="Substrate; via carbonyl oxygen" evidence="16">
<location>
<position position="67"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="15">
<location>
<position position="98"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="15">
<location>
<position position="174"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="16">
<location>
<position position="219"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="16">
<location>
<position position="285"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="16">
<location>
<position position="313"/>
</location>
</feature>
<feature type="site" description="Cleavage; by caspase-3" evidence="23">
<location>
<begin position="413"/>
<end position="414"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11 12 13 14">
<location>
<position position="364"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_020866" evidence="33">
<location>
<begin position="346"/>
<end position="398"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_020867" evidence="32">
<original>CRSHSSAQFLIGDQE</original>
<variation>RCTRNNLFSSNILSL</variation>
<location>
<begin position="663"/>
<end position="677"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_020868" evidence="32">
<location>
<begin position="678"/>
<end position="916"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_020869" evidence="33">
<location>
<begin position="691"/>
<end position="704"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3740421." id="VAR_027761">
<original>G</original>
<variation>E</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17853930." id="VAR_027762" evidence="21">
<original>E</original>
<variation>K</variation>
<location>
<position position="602"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces affinity for glycopeptide substrates. Nearly abolishes enzyme activity." evidence="25 26">
<original>Y</original>
<variation>K</variation>
<variation>Q</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces affinity for glycopeptide substrates. Nearly abolishes enzyme activity." evidence="25 26">
<original>Y</original>
<variation>S</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nearly abolishes enzyme activity." evidence="22">
<original>D</original>
<variation>A</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nearly abolishes enzyme activity." evidence="22">
<original>D</original>
<variation>A</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nearly abolishes enzyme activity." evidence="25">
<original>D</original>
<variation>N</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nearly abolishes enzyme activity." evidence="25">
<original>V</original>
<variation>G</variation>
<variation>T</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nearly abolishes enzyme activity." evidence="25">
<original>Y</original>
<variation>S</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nearly abolishes enzyme activity." evidence="25">
<original>D</original>
<variation>A</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates cleavage by caspase-3." evidence="23">
<original>D</original>
<variation>A</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nearly abolishes enzyme activity." evidence="25">
<original>W</original>
<variation>N</variation>
<location>
<position position="679"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="50"/>
<end position="52"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="54"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="61"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="69"/>
<end position="71"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="75"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="92"/>
<end position="95"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="101"/>
<end position="103"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="104"/>
<end position="108"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="113"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="132"/>
<end position="137"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="140"/>
<end position="142"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="148"/>
<end position="162"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="168"/>
<end position="172"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="182"/>
<end position="187"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="188"/>
<end position="190"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="191"/>
<end position="205"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="212"/>
<end position="215"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="224"/>
<end position="226"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="228"/>
<end position="230"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="232"/>
<end position="240"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="245"/>
<end position="249"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="252"/>
<end position="255"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="261"/>
<end position="271"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="276"/>
<end position="279"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="285"/>
<end position="287"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="301"/>
<end position="306"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="308"/>
<end position="312"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="318"/>
<end position="321"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="322"/>
<end position="332"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="334"/>
<end position="337"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="376"/>
<end position="388"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="389"/>
<end position="391"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="542"/>
<end position="544"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="555"/>
<end position="564"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="573"/>
<end position="587"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="589"/>
<end position="591"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="601"/>
<end position="603"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="605"/>
<end position="628"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="634"/>
<end position="661"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="662"/>
<end position="666"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="680"/>
<end position="683"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="684"/>
<end position="692"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="694"/>
<end position="699"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="710"/>
<end position="712"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5M7R"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5M7T"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UHK"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UHL"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UHP"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UN8"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5VVU"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6HKI"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6PM9"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q0TR53"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q2CEE3"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9EQQ9"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11148210"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11341771"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11788610"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16533067"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18586680"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20673219"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20863279"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22365600"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24088714"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28742148"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11148210"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11788610"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20863279"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9811929"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000305"/>
<evidence key="34" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16533067"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20673219"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="24088714"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:7056"/>
</source>
</evidence>
<sequence length="916" mass="102915" checksum="01F8A64A9B1475C6" modified="2001-03-01" version="2">MVQKESQATLEERESELSSNPAASAGASLEPPAAPAPGEDNPAGAGGAAVAGAAGGARRFLCGVVEGFYGRPWVMEQRKELFRRLQKWELNTYLYAPKDDYKHRMFWREMYSVEEAEQLMTLISAAREYEIEFIYAISPGLDITFSNPKEVSTLKRKLDQVSQFGCRSFALLFDDIDHNMCAADKEVFSSFAHAQVSITNEIYQYLGEPETFLFCPTEYCGTFCYPNVSQSPYLRTVGEKLLPGIEVLWTGPKVVSKEIPVESIEEVSKIIKRAPVIWDNIHANDYDQKRLFLGPYKGRSTELIPRLKGVLTNPNCEFEANYVAIHTLATWYKSNMNGVRKDVVMTDSEDSTVSIQIKLENEGSDEDIETDVLYSPQMALKLALTEWLQEFGVPHQYSSRQVAHSGAKASVVDGTPLVAAPSLNATTVVTTVYQEPIMSQGAALSGEPTTLTKEEEKKQPDEEPMDMVVEKQEETDHKNDNQILSEIVEAKMAEELKPMDTDKESIAESKSPEMSMQEDCISDIAPMQTDEQTNKEQFVPGPNEKPLYTAEPVTLEDLQLLADLFYLPYEHGPKGAQMLREFQWLRANSSVVSVNCKGKDSEKIEEWRSRAAKFEEMCGLVMGMFTRLSNCANRTILYDMYSYVWDIKSIMSMVKSFVQWLGCRSHSSAQFLIGDQEPWAFRGGLAGEFQRLLPIDGANDLFFQPPPLTPTSKVYTIRPYFPKDEASVYKICREMYDDGVGLPFQSQPDLIGDKLVGGLLSLSLDYCFVLEDEDGICGYALGTVDVTPFIKKCKISWIPFMQEKYTKPNGDKELSEAEKIMLSFHEEQEVLPETFLANFPSLIKMDIHKKVTDPSVAKSMMACLLSSLKANGSRGAFCEVRPDDKRILEFYSKLGCFEIAKMEGFPKDVVILGRSL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

